US SEC Filings Daily Market Digest — July 15, 2026

14-07-2026

Actelis Networks Inc. (ASNS) received a final delisting determination from Nasdaq, with its common stock to be removed from listing effective July 23, 2026. The delisting follows a process that began with a Staff determination on February 4, 2026, an unsuccessful appeal to a Hearings Panel, and a suspension on April 10, 2026. The company failed to meet Nasdaq's minimum bid price requirement under Listing Rule 5550(a)(2), and all appeals have been exhausted.

• · The delisting is effective at the opening of the trading session on July 23, 2026.
• · The company's common stock was suspended from trading on April 10, 2026.
• · The Staff determination to delist became final on May 26, 2026.
• · The company failed to meet the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

14-07-2026

American Rebel Holdings Inc. (AREBW) has been formally delisted from Nasdaq, with trading suspended on May 13, 2026, and the delisting effective July 23, 2026. The delisting follows Nasdaq Staff determinations that the company failed to meet Listing Rules 5550(a)(2) (bid price) and 5550(a)(4) (other requirements), and the company's appeal to the Hearings Panel was denied. This represents a significant negative event for shareholders, as the company loses its Nasdaq listing and associated liquidity.

• · Delisting effective at the opening of trading on July 23, 2026.
• · Trading was suspended on May 13, 2026, after the Panel's decision.
• · The Staff determination to delist became final on June 25, 2026.
• · The company failed to meet Listing Rule 5550(a)(2) (bid price requirement) and Listing Rule 5550(a)(4) (other listing requirements).
• · The company appealed the Staff determination on February 11, 2026, but the Panel upheld the delisting on May 11, 2026.

14-07-2026

Blue Hat Interactive Entertainment Technology (BHAT) has been delisted from Nasdaq following a determination that it no longer met Listing Rule 5550(a)(2). The company's shares were suspended on March 16, 2026, and the Staff's delisting decision became final on June 8, 2026. The delisting will be effective from the opening of trading on July 23, 2026.

• · Delisting is due to non-compliance with Nasdaq Listing Rule 5550(a)(2) (minimum bid price or market value of publicly held shares).
• · Staff determination was initially made on March 9, 2026.
• · Company appealed the decision on March 13, 2026; a hearing was held on April 7, 2026.
• · The Panel issued a decision on April 21, 2026 (letter issued April 22, 2026) to suspend the company from the Exchange.
• · Shares were suspended on March 16, 2026.
• · Delisting is effective at the opening of the trading session on July 23, 2026.

14-07-2026

Captivision Inc. (CAPTW) has been formally delisted from Nasdaq, effective July 23, 2026, after failing to regain compliance with Listing Rule 5450(b)(2)(A). The company was initially notified of non-compliance in June 2025, granted an appeal and extension, but ultimately suspended on April 9, 2026, with the delisting determination becoming final on May 22, 2026. This represents a significant negative event for shareholders, as the company's securities will no longer trade on a major U.S. exchange.

• · Initial non-compliance notice was issued on June 4, 2025.
• · Company appealed on June 11, 2025, and a hearing was held on July 22, 2025.
• · The Panel initially granted a conditional extension on July 25, 2025.
• · On April 6, 2026, the Panel decided to suspend the company because it was unable to regain compliance despite an extended period.
• · Securities were suspended on April 9, 2026.
• · The delisting determination became final on May 22, 2026.
• · The delisting is effective at the opening of trading on July 23, 2026.

14-07-2026

Sleep Number Corp (SNBR) is being delisted from Nasdaq effective July 23, 2026, after Nasdaq Staff determined the company no longer met listing qualifications under Rules 5101, 5110(b), and IM-5101-1. The company did not appeal the delisting determination, and its common stock was suspended on June 23, 2026. This marks a significant negative event for shareholders, as the stock will no longer trade on a major exchange.

• · Delisting effective at the opening of the trading session on July 23, 2026.
• · Nasdaq Staff determination was made on June 16, 2026.
• · Company did not appeal the Staff's Delist Determination Letter.
• · Company common stock was suspended on June 23, 2026.
• · Staff determination to delist became final on June 23, 2026.
• · Delisting based on Listing Rules 5101, 5110(b), and IM-5101-1.

14-07-2026

Nasdaq has determined to delist X3 Holdings Co., Ltd. (XTKG) effective July 23, 2026, after the company failed to meet Listing Rule 5550(a)(2) regarding minimum bid price. The company's shares were suspended on April 2, 2026, following an unsuccessful appeal to the Nasdaq Hearings Panel, and the delisting determination became final on May 15, 2026.

• · The company was originally notified of the Staff determination on February 10, 2026.
• · The company appealed the determination on February 11, 2026, and a hearing was held on March 19, 2026.
• · The Panel decided to suspend the company on March 27, 2026, with a decision letter issued on March 31, 2026.
• · Shares were suspended on April 2, 2026.
• · The delisting determination became final on May 15, 2026.
• · The company was formerly known as Powerbridge Technologies Co., Ltd. (name changed September 26, 2018).

15-07-2026

SK hynix Inc. announced it will hold a conference call on July 29, 2026, to discuss its second-quarter 2026 earnings results. The call will be webcast in Korean and English, with materials available on the company's IR website. No financial results or performance data are included in this filing.

• · Conference call scheduled for July 29, 2026 at 9:00 a.m. Seoul Time
• · Webcast archive will be available on the company's IR website
• · Materials will be posted on July 29, 2026 (Seoul time)

15-07-2026

Sinovac Biotech Ltd. announced a further extension of the deadline for shareholders and nominee brokers to submit payment instructions for its previously declared special cash dividend of US$55.00 per common share. The submission deadline has been extended from June 30, 2026 to December 31, 2026. This is the second extension of the deadline, indicating ongoing administrative delays in distributing the dividend.

• · Record date for the special dividend was May 23, 2025 ET.
• · Original submission deadline was December 31, 2025, first extended to June 30, 2026, now further extended to December 31, 2026.
• · Shareholders and nominee brokers must submit instruction materials by December 31, 2026 to receive payment.
• · Information agent: D.F. King & Co., Inc., 28 Liberty Street, 53rd Floor, New York, NY 10005, email: sva@dfking.com.

15-07-2026

SemiLEDs Corporation filed its definitive proxy statement (DEF 14A) on July 15, 2026, for the 2026 Annual Meeting of Stockholders to be held on August 28, 2026. The agenda includes the election of five director nominees (including Chairman/CEO Trung T. Doan and three independent directors) and ratification of DLEE Accountancy Inc. as independent auditor for fiscal year 2026. The company has 8,273,403 shares of common stock outstanding as of the record date of July 1, 2026.

• · Annual meeting will be held on Friday, August 28, 2026 at 9 a.m. local time at SemiLEDs office in Chu-Nan, Taiwan.
• · Record date for voting is July 1, 2026.
• · Quorum requires holders of more than one third of voting power present in person or by proxy.
• · Proxies submitted by Internet or telephone must be received by 11:59 p.m. Eastern Standard Time on August 26, 2025 (note: year appears to be a typo in the filing).
• · Election of directors is determined by plurality of votes; ratification of auditor is determined by majority of votes cast affirmatively or negatively.
• · Broker non-votes will have no effect on either proposal.
• · The Board recommends a vote FOR all five director nominees and FOR ratification of DLEE Accountancy Inc.

15-07-2026

Polibeli Group Ltd has entered into a non-binding Memorandum of Understanding with PT Grosirone Prima Nusantara to evaluate a potential AI data center project in Indonesia. The project, if pursued, could involve up to approximately 10MW of power capacity, with an initial phase of 2MW to 5MW. However, the MOU is non-binding and does not obligate either party to proceed; the project remains subject to due diligence, approvals, and definitive agreements, with no assurance of completion.

• · The MOU was entered into on July 1, 2026.
• · The MOU covers preliminary evaluation of colocation data center facilities, power supply, cooling systems, network connectivity, and commercial feasibility.
• · The MOU is non-binding except for confidentiality, compliance, governing law, and dispute resolution provisions.
• · Any definitive transaction requires satisfactory due diligence, internal approvals, financing availability, and regulatory approvals.

15-07-2026

ASML Holding N.V. reported Q2 2026 total net sales of €9.3 billion and net income of €2.9 billion. The company raised its full-year 2026 outlook, now expecting total net sales between €43 billion and €45 billion with a gross margin between 54% and 56%. The filing includes a press release, investor presentation, US GAAP financial statements, and an interim report for the six-month period ended June 28, 2026.

• · The filing incorporates exhibits 99.1, 99.3, and 99.4 by reference into multiple S-8 registration statements (File Nos. 333-203390, 333-219442, 333-227464, 333-291580).
• · The statutory interim report covers the six-month period ended June 28, 2026.

15-07-2026

AEON Biopharma priced a public offering of 17,851,599 shares of common stock and pre-funded warrants to purchase 24,837,008 shares, each accompanied by milestone warrants, at a combined price of $0.3221 per share and $0.3220 per pre-funded warrant, for total gross proceeds of approximately $13.75 million. The offering includes two-year and five-year milestone warrants tied to FDA and clinical milestones for ABP-450, a biosimilar to BOTOX. Proceeds will be used to advance ABP-450 through the 351(k) biosimilar pathway toward a BLA in the U.S., targeting a therapeutic botulinum toxin market estimated at $3.5 billion in 2026.

• · Milestone warrants expire upon FDA Type 2B meeting minutes (two-year) or initiation of Phase 3 trial (five-year), plus 45 days after public announcement.
• · Pre-funded warrants have an exercise price of $0.0001 per share and are exercisable immediately until exercised in full.
• · Milestone warrants are not listed and no trading market is expected; underlying common stock will trade on NYSE American.
• · Underwriters received a reduced discount of 5.0% on 2,328,469 shares and 12,418,504 pre-funded warrants.
• · ABP-450 is manufactured by Daewoong Pharmaceutical and is already approved as a biosimilar in Mexico, India, and the Philippines.

15-07-2026

ICICI Bank has informed exchanges that its Board meeting scheduled for July 18, 2026 will consider revising the fund raising limit through issuance of bonds/notes/offshore certificates of deposit in overseas markets. This is a routine corporate action update with no financial figures disclosed.

• · Board meeting scheduled for July 18, 2026
• · Revision of fund raising limit via overseas market instruments to be considered
• · Disclosure made under SEBI Regulations 29 & 50

15-07-2026

NetEase, Inc. filed a Form 6-K with the SEC on July 15, 2026, reporting the amendment and restatement of its 2019 Share Incentive Plan, effective June 30, 2026, in connection with its conversion to dual primary listing status on the Hong Kong Stock Exchange. The Second Amended and Restated 2019 Plan is attached as Exhibit 99.1 and incorporated by reference into the company's Form S-8 registration statement. The filing is a routine corporate governance update with no financial figures or performance data.

• · The Second Amended and Restated 2019 Plan took effect on June 30, 2026.
• · The plan is incorporated by reference into NetEase's Registration Statement on Form S-8 (File No. 333-234189).
• · The filing is made under Commission File Number 000-30666.

15-07-2026

Trellis Wealth Advisors LLC filed its quarterly 13F-HR for the period ending June 30, 2026, reporting total holdings of approximately $291.3 million across 49 equity positions. The portfolio is heavily weighted toward ETFs, with the largest positions in Dimensional ETF Trust World Ex US Core ($58.8M), Dimensional ETF Trust US Cor Equ 2 ETF ($43.2M), and Vanguard Index Fds Total Stk Mkt ($31.3M). Top individual stock holdings include Amazon.com ($4.9M), Microsoft ($985K), and Alphabet Class A ($421K) and Class C ($480K). The filing shows a diversified, ETF-centric strategy with significant international and fixed-income exposure.

• · The filing was signed by Carrie Miller, Partner, on July 15, 2026.
• · All 49 positions are held with sole voting and dispositive power; no shared positions are reported.
• · The portfolio includes a small position in Blend Labs Inc Class A valued at approximately $18,694, indicating a speculative or early-stage investment.
• · The largest single stock holding is Amazon.com Inc at $4.9M, followed by Microsoft at $985K and Apple at $783K.
• · ETF holdings dominate the portfolio, with the top 10 ETF positions accounting for over $200M of the total $291M.
• · The portfolio has significant international exposure through Dimensional World Ex US Core ($58.8M), Vanguard Total Intl Stock ($9.9M), and American Century Intl Eqt ETF ($22.3M).
• · Fixed-income exposure is notable via Vanguard Short Term Bond ($22.4M), Vanguard Total Bond ($14.9M), and Vanguard Short Term Corp Bond ($9.6M).

15-07-2026

Purebase Corporation filed a Form NT 10-Q on July 15, 2026, indicating it will not file its quarterly report for the period ended May 31, 2026 by the prescribed due date. The company cites the need for additional time to finalize certain disclosures, but does not anticipate any significant change in results of operations compared to the prior year. The filing is a routine late notification with no negative financial implications disclosed.

• · The report will be filed within five calendar days of the prescribed due date (by July 20, 2026).
• · All other periodic reports required in the preceding 12 months have been filed.
• · No significant change in results of operations from the prior year is anticipated.

15-07-2026

Honda Motor Co., Ltd. disclosed its principal shareholders as of a recent date, with The Master Trust Bank of Japan (Trust Account) holding 682,319 thousand shares (17.50%) and Custody Bank of Japan (Trust Account) holding 275,945 thousand shares (7.08%). The filing also outlines corporate governance systems required under Japan's Financial Instruments and Exchange Law, including provisions for the Audit Committee and whistleblower protections. No financial results or period-over-period comparisons are provided.

• · The Master Trust Bank of Japan (Trust Account) is the largest shareholder with 17.50% of total shares issued.
• · Custody Bank of Japan (Trust Account) holds 7.08% as the second-largest shareholder.
• · Moxley & Co. LLC holds 5.72% of shares, making it the third-largest shareholder.
• · The filing includes governance disclosures regarding the Audit Committee and whistleblower protections under Japanese law.

15-07-2026

M&T Bank Corporation reported record diluted EPS of $5.32 for Q2 2026, up 29% QoQ from $4.13 and 25% YoY from $4.24. Net income rose to $818M from $664M in Q1 2026 and $716M in Q2 2025, driven by higher net interest income (+2% QoQ, +5% YoY) and noninterest income (+8% QoQ and YoY). However, the net interest margin remained flat at 3.70% QoQ, and the CET1 capital ratio declined to an estimated 10.19% from 10.33% in Q1 2026 and 10.99% a year ago.

• · Average commercial real estate loans declined 7% YoY to $23.6B, reflecting payoffs.
• · Average interest-bearing deposits at banks fell 24% YoY to $15.1B as liquidity was deployed into loans and securities.
• · Average short-term borrowings surged 141% QoQ to $8.0B and 141% YoY, driven by FHLB advances.
• · Average long-term borrowings increased 15% QoQ and 17% YoY due to senior note issuances and securitizations.
• · Nonaccrual loans improved 23% YoY to $1.2B, driven by declines in commercial and industrial and commercial real estate categories.
• · Net charge-offs fell 23% QoQ and 26% YoY to $80M, with annualized net charge-off rate of 0.23%.
• · Allowance for loan losses to total loans declined to 1.52% from 1.61% a year ago, reflecting lower criticized loans.
• · Efficiency ratio improved to 52.8% from 58.3% in Q1 2026 and 55.2% in Q2 2025.
• · Return on average common equity (annualized) rose to 12.30% from 9.67% in Q1 2026 and 10.39% in Q2 2025.
• · Return on average tangible common equity (annualized) was 18.57% in Q2 2026, up from 14.51% in Q1 2026 and 15.54% in Q2 2025.
• · Tangible equity per common share increased to $117.41 from $115.96 in Q1 2026 and $112.48 in Q2 2025.
• · The company repurchased 2.1 million shares at a total cost of $465 million during Q2 2026.

15-07-2026

Comprehensive Financial Consultants Institutional, Inc. filed its Form 13F-HR for the quarter ended June 30, 2026, reporting a portfolio of 205 equity holdings with a total market value of approximately $378.1 million. The filing reflects a diversified portfolio spanning large-cap equities, sector-specific ETFs, and defined-outcome ETFs, with top holdings including Apple Inc., Eli Lilly & Co., and JPMorgan Chase & Co. No prior-period comparison is available in this filing, so period-over-period trends cannot be assessed.

• · The portfolio includes a put option on Micron Technology Inc. (202 shares).
• · The largest single holding by market value is Apple Inc. at approximately $8.14 million.
• · The portfolio holds a significant position in Nuburu Inc. (20,040 shares), a small-cap stock valued at only $2,567.
• · The filing includes a substantial allocation to defined-outcome ETFs from Innovator ETFs Trust, with the largest being the U.S. Equity 10 Buffer ETF (136,367 shares, ~$4.62 million).
• · The portfolio contains 205 total holdings, all reported as sole voting and dispositive power.

15-07-2026

POSCO HOLDINGS INC. filed a Form 6-K with the SEC on July 15, 2026, announcing a conference call on July 30, 2026, to discuss provisional earnings for the second quarter of 2026 and its business plan. The call will be open to analysts, institutional investors, and the press. No financial results or performance data are disclosed in this filing.

• · The conference call is scheduled for July 30, 2026, at 3:00 PM KST.
• · The agenda includes provisional earnings for Q2 2026 and a Q&A session.
• · Participants include analysts, institutional investors, and the press.

15-07-2026

AITX reported Q1 FY2027 total revenue of $1.83M, down ~1% YoY and ~8% sequentially, as reduced sales to its largest customer (down 59% YoY to $367,883) offset strong growth elsewhere. Revenue excluding the largest customer surged 52% YoY to $1.46M, operating expenses fell 12%, and operating loss narrowed 15% to $2.71M. However, net loss widened 24% to $5.72M due to higher non-operating costs, and cash burn improved 17% to $2.76M. Preliminary June recurring monthly revenue rose 15% MoM, aided by initial SARA activations ($10K) and two ROAMEO units, but the company cautioned that a single month does not establish a trend.

• · Net loss per share (basic and diluted) was $(0.02) vs $(0.03) in prior year.
• · Weighted average share count increased to ~326.0M from ~155.2M YoY.
• · SARA backlog represents ~$100K in additional potential recurring monthly revenue once fully deployed.
• · Company discontinued RADCam Residential initiative and redirected resources to enterprise.
• · More than 200 RADCam units have been deployed in enterprise settings.
• · Management targets at least one month of positive cash flow from operations during calendar 2026.
• · Q2 FY2027 revenue expected to exceed Q1 by more than 10% (preliminary outlook).

15-07-2026

Baosheng Media Group Holdings Ltd filed a Form 6-K with the SEC on July 15, 2026, incorporating legal opinions and consents into its existing F-3 registration statement. The filing is a routine procedural step to support its securities registration and does not disclose any new financial or operational results.

• · The filing incorporates by reference legal opinions from Maples and Calder (Hong Kong) LLP and CFN Lawyers LLC, along with their consents, into the company's Form F-3 registration statement (File No. 333-273720).
• · The report is signed by Chairwoman and CEO Lina Jiang and dated July 14, 2026.

15-07-2026

Elevance Health reported Q2 2026 operating revenue of $49.8B, up 0.8% YoY, and adjusted diluted EPS of $7.45, beating expectations and supported by favorable benefit expense performance and a net below-the-line benefit of ~$0.80 per share. However, GAAP diluted EPS fell 13.1% to $6.71, operating gain dropped 27.3% to $1.8B, and the Health Benefits segment saw a 42.6% decline in operating gain to $0.9B due to higher benefit expense and targeted investments. The company raised full-year adjusted EPS guidance to at least $27.00 and operating cash flow guidance to at least $6.0B.

• · Days in Claims Payable stood at 45.4 days as of June 30, 2026, a decrease of 1.2 days from March 31, 2026 and an increase of 2.9 days year over year.
• · The operating expense ratio was 11.1%; adjusted operating expense ratio was 11.0%, up 100 bps YoY due to targeted investments.
• · CarelonRx operating margin improved 20 bps YoY to 5.2%, while Carelon Services operating margin declined 80 bps to 4.6%.
• · Health Benefits operating margin fell 170 bps YoY to 2.1%.
• · Commercial risk-based membership declined 4.6% YoY; Employer Group risk-based declined 5.5% YoY.
• · Individual ACA membership declined 2.3% YoY and 7.5% sequentially.
• · Federal Employee Program membership declined 5.4% YoY.
• · Net income attributable to shareholders declined 16.1% YoY to $1.463B.
• · Operating cash flow for the first half of 2026 was $6.245B, up from $3.071B in the prior year period.
• · The company raised FY 2026 GAAP diluted EPS guidance to at least $20.10 and adjusted diluted EPS to at least $27.00.
• · The company declared a Q3 2026 dividend of $1.72 per share, payable September 25, 2026.

15-07-2026

Ceragon Networks Ltd. announced a $3.4 million two-year managed services contract with a major mobile operator in Mexico. The contract is expected to contribute to the company's services revenue over the contract period.

• · The contract is with a major mobile operator in Mexico.
• · The contract duration is two years.
• · The contract was awarded in July 2026.

15-07-2026

United Microelectronics Corporation (UMC) filed a Form 6-K with the SEC on July 15, 2026, submitted by CFO Chitung Liu. The filing is a routine foreign issuer report and does not contain any financial results, material events, or operational updates beyond the cover page and signature block.

15-07-2026

Fractyl Health reported one-year data from its REMAIN-1 Midpoint Cohort showing that a single Revita procedure reduced weight regain by approximately 40% versus sham in the full mITT population (7.8% vs 13.0% weight regain). In patients with complete duodenal ablation (>14 cm), Revita maintained approximately 81% of GLP-1-induced weight loss at one year, compared with 48% in sham, and the weight-maintenance responder rate reached 73% in the mITT population and 91% in those with complete ablation. However, the study is a small, non-pivotal cohort (N=45), and the results are preliminary; the company still faces the risk that the larger Pivotal Cohort may not meet its FDA-mandated performance goal.

• · No device- or procedure-related serious adverse events occurred.
• · No new device-related TEAEs were observed between six and 12 months.
• · One new diagnosis of type 2 diabetes occurred in the sham arm versus none with Revita.
• · The second co-primary endpoint of the Pivotal Cohort is assessed against an FDA-mandated pre-specified performance goal of >50%.
• · The company will host a conference call on July 15, 2026 at 8:00 a.m. ET.

15-07-2026

Titan Mining Corporation filed a Form 6-K with the SEC on July 15, 2026, submitting a press release dated the same day. The filing is a routine foreign issuer report and does not contain any financial results or material operational updates.

• · The filing is made under Form 40-F (not Form 20-F).
• · The press release (Exhibit 99.1) is dated July 15, 2026.
• · Commission file number: 001-42955.

15-07-2026

BlackRock, Inc. has notified Caledonia Mining Corporation Plc that its total voting rights in the company crossed a threshold on July 13, 2026, resulting in a combined position of 6.22% (1,203,763 voting rights). This represents a slight increase from the previous notification of 6.17%, driven by a reduction in direct voting rights (from 5.25% to 4.92%) but an increase in voting rights through financial instruments (from 0.91% to 1.30%). The change is primarily due to a decrease in direct shareholdings and an increase in securities lending and CFD positions.

• · BlackRock's direct voting rights decreased from 5.25% to 4.92%, while indirect voting rights through financial instruments increased from 0.91% to 1.30%.
• · The financial instruments include securities lending (0.89% or 173,959 voting rights) and CFDs (0.40% or 77,610 voting rights).
• · The notification was made to the FCA under DTR5 rules, with the threshold crossed on July 13, 2026, and the issuer notified on July 14, 2026.

15-07-2026

Cordant, Inc. filed its quarterly 13F-HR with the SEC for the period ending June 30, 2026, disclosing its equity portfolio as of that date. The filing reports holdings in 353 securities with a total aggregate fair value of approximately $279.4 million. The portfolio is heavily weighted toward ETFs, including significant positions in Dimensional ETF Trust funds, iShares ETFs, and Invesco commodity and equity ETFs, alongside notable individual stock holdings in Intel, Amazon, Alphabet, and Microsoft.

• · The filing was submitted on July 15, 2026, for the period ending June 30, 2026.
• · The portfolio includes 353 distinct securities.
• · The largest individual equity holdings by value include Intel Corp ($4.3M), Amazon.com ($1.5M), Alphabet Inc. Class C ($2.6M), and Microsoft Corp ($422k).
• · Significant ETF positions include Invesco DB Commodity Index Tracking Fund ($11.2M), iShares Core MSCI Emerging Markets ETF ($3.8M), iShares Core MSCI International ETF ($3.6M), iShares TIPS Bond ETF ($3.7M), and iShares U.S. Real Estate ETF ($1.9M).
• · Dimensional ETF Trust funds collectively represent a large portion of the portfolio, with holdings in Emerging Markets Value, International Value, US Large Value, US Small Cap, and other strategies.
• · The filing is a combination report filed by Cordant, Inc. as an institutional investment manager.

15-07-2026

Strive, Inc. (ASST) announced on July 14, 2026 that its board of directors maintained the regular dividend rate on its Variable Rate Series A Perpetual Preferred Stock (SATA) at 13.00% per annum, effective for periods from August 1, 2026. The company declared daily cash dividends of $0.0516 per share (aggregate $1.0836 per share for the full monthly period) for 21 business days from August 3 to August 31, 2026. From a U.S. federal income tax perspective, distributions are expected to be treated as tax-deferred return of capital, as the company has no accumulated or current earnings and profits and does not expect to generate any in the foreseeable future.

• · Dividend rate of 13.00% per annum on SATA Stock maintained, effective for periods on or after August 1, 2026.
• · Daily cash dividends of $0.0516 per share declared for each business day from August 3, 2026 through August 31, 2026 (21 business days).
• · Aggregate monthly dividend per share for the period is $1.0836.
• · Dividends will be paid to stockholders of record at the close of business on the immediately preceding business day.
• · From a U.S. federal income tax perspective, distributions not treated as from earnings and profits will be tax-deferred return of capital for U.S. investors and exempt from U.S. dividend withholding tax for non-U.S. investors.
• · The company has no accumulated earnings and profits and does not expect to generate current earnings and profits in the current year or foreseeable future.

15-07-2026

Sunbelt Rentals Holdings, Inc. completed the issuance of $450M in 4.950% Senior Notes due 2030 and $750M in 5.650% Senior Notes due 2036 on July 14, 2026. The notes were issued at discounts of 99.627% and 99.048%, respectively, and are guaranteed by the company's domestic subsidiaries. The proceeds will be used for general corporate purposes, and the notes rank equally with existing senior debt.

• · The notes were issued in a private placement exempt from SEC registration under Rule 144A and Regulation S.
• · Interest on both notes is payable semi-annually on February 12 and August 12, beginning February 12, 2027.
• · The company may redeem the 2030 Notes at any time prior to July 12, 2030 at specified redemption prices, and at par thereafter.
• · The company may redeem the 2036 Notes at any time prior to May 12, 2036 at specified redemption prices, and at par thereafter.
• · Upon a change-in-control triggering event, the company must offer to repurchase the notes at 101% of principal plus accrued interest.
• · The indenture includes covenants limiting sale/leaseback transactions, liens on assets, and mergers/asset sales, with customary exceptions.
• · Events of default include nonpayment, covenant breaches, payment defaults on other indebtedness, and bankruptcy/insolvency.

15-07-2026

Nicola Mining Inc. filed a Form 6-K with the SEC for July 2026, attaching a news release dated June 26, 2026. The filing is a routine foreign private issuer report under Rule 13a-16 or 15d-16, with no financial results or material operational updates disclosed in the cover.

• · Filing date: July 15, 2026
• · Commission file number: 001-43228
• · Exhibit 99.1 is a news release dated June 26, 2026
• · Registrant is a Canadian company with principal executive offices in Vancouver, British Columbia
• · The registrant files annual reports under Form 40-F

15-07-2026

Twin Vee PowerCats Co. (VEEE) entered into a definitive merger agreement on July 12, 2026, under which a wholly-owned subsidiary of USFM Corporation will merge into Twin Vee, with Twin Vee surviving as a wholly-owned subsidiary of USFM. Existing Twin Vee shareholders will receive a pro rata portion of shares representing 10% of USFM's outstanding common stock on a fully diluted basis. Concurrently, CEO Joseph Visconti resigned as Interim CFO and was replaced by Michael P. Dickerson, who received a grant of 3,970 RSUs and cash payments totaling $50,000 upon signing and closing of the merger. The merger is subject to stockholder approvals from both companies and other customary conditions, with a termination fee of $500,000 payable by Acquiror to Twin Vee under certain circumstances and $1,500,000 payable by Twin Vee to Acquiror if Twin Vee terminates for a superior proposal.

• · The merger agreement includes a 'fiduciary-out' provision allowing Twin Vee's board to change its recommendation or provide information to third parties if required by fiduciary duties.
• · A Pre-Closing CVR Restructuring will transfer Twin Vee's existing assets and liabilities to a newly formed trust (Assetco), with contingent value rights distributed to existing Twin Vee stockholders; net proceeds from future asset sales will benefit those stockholders.
• · The merger must close by October 31, 2026 (end date), or either party may terminate under certain conditions.
• · Michael P. Dickerson previously served as Twin Vee's Chief Financial & Administrative Officer from April 2024 through February 2026 and has over 35 years of corporate experience.
• · A Company stockholder entered into a Support Agreement to vote in favor of the merger and against any alternative proposal.

15-07-2026

Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. filed its quarterly 13F-HR for the period ending June 30, 2026, disclosing a portfolio of 158 equity holdings with a total market value of approximately $32.7 billion. The filing shows a diversified portfolio heavily weighted toward mega-cap U.S. technology and financial stocks, with top holdings including NVIDIA Corporation ($7.14M shares), Apple Inc. ($11.08M shares), and Microsoft Corporation ($2.57M shares). The filing does not provide period-over-period comparisons, so no growth or decline metrics are available.

• · The filing was signed by Hidetoshi Fuwa, Chief Manager of Corporate Planning Division, on July 14, 2026.
• · The portfolio includes 158 equity positions with a total market value of $32,709,549,000 (in thousands).
• · Top holdings by share count include NVIDIA Corporation (7,140,000 shares), Apple Inc. (11,082,583 shares), Microsoft Corporation (2,567,000 shares), Amazon.com Inc. (2,345,000 shares), and Alphabet Inc. (2,160,300 shares).
• · The filing also includes holdings in SPDR Gold Trust (2,260,000 shares) and Invesco QQQ Trust (1,590,000 shares).
• · No period-over-period comparisons are available as this is a snapshot filing.

15-07-2026

Gossamer Bio, Inc. filed an 8-K on July 15, 2026, reporting that at a special meeting of stockholders held on July 14, 2026, shareholders approved an amendment to the company's Amended and Restated Certificate of Incorporation. The amendment increases the authorized capital stock from an unspecified prior amount to 4,070,000,000 shares, consisting of 4,000,000,000 shares of Common Stock and 70,000,000 shares of Preferred Stock. The filing also covers items related to director/officer changes (Items 5.02, 5.03, 5.07, 9.01), but the exhibit only details the charter amendment; no specific officer departures or elections are described in the provided content.

• · The amendment was approved at a special meeting of stockholders held on July 14, 2026.
• · The certificate of amendment was executed on July 14, 2026, and filed with the Delaware Secretary of State.
• · The company was originally known as FSG Bio, Inc. and filed its original Certificate of Incorporation on October 26, 2015.
• · The par value per share for both Common and Preferred Stock is $0.0001.

15-07-2026

Americas Gold and Silver Corporation filed a Form 6-K with the SEC for June 2026, attaching a news release dated June 25, 2026. The filing is a routine foreign issuer report and does not contain any financial results or material operational updates.

15-07-2026

Trillion Energy International Inc. announced an amendment to its M47 farm-in agreement, gaining additional financial flexibility through 2027 for its earn-in commitments. The amendment was disclosed via a news release on July 9, 2026, and filed with the SEC on July 15, 2026. No specific financial figures or performance metrics were provided in the filing.

• · The amendment provides additional financial flexibility through 2027 for earn-in commitments.
• · The news release was issued on July 9, 2026.
• · The filing was signed by David Thompson, Director and Audit Committee Chair, on July 14, 2026.

15-07-2026

Wealth Advisors Northwest LLC filed its quarterly 13F-HR for the period ending June 30, 2026, reporting a total of 65 equity holdings with an aggregate market value of approximately $293.2 million. The portfolio is heavily concentrated in Dimensional ETF Trust funds, which account for the majority of the holdings, alongside significant positions in major tech and growth stocks such as Amazon, Apple, Microsoft, and Tesla. The filing reflects a diversified, ETF-centric investment strategy with a tilt toward U.S. core equity and high-profitability factors.

• · The largest single holding is Dimensional ETF Trust US Cor Equ 2 ETF with a market value of $70,308,089 (1,584,943 shares).
• · Other top Dimensional ETF holdings include US High Prof ETF ($18,946,549), US Small Cap ETF ($21,917,002), Intl Core Equity ($21,003,306), and Glob Co Plus ETF ($29,322,543).
• · Among individual stocks, the largest positions are Amazon.com ($10,698,368), Apple ($2,273,081), Tesla ($2,175,343), Microsoft ($1,607,978), and Netflix ($1,045,939).
• · The portfolio includes 23 distinct Dimensional ETF Trust funds, reflecting a strong factor-based and passive investment approach.
• · No period-over-period comparisons are available as this is a single-period filing without prior quarter data.

15-07-2026

Weitzel Financial Services, Inc. filed its quarterly 13F-HR report for the period ending June 30, 2026, disclosing 51 equity holdings with a total reported value of approximately $294.1 million. The portfolio is heavily weighted toward fixed-income and balanced ETFs, with the largest positions in the SPDR Portfolio S&P 1500 Composite Stock Market ETF ($61.8M), Vanguard FTSE Developed Markets ETF ($43.4M), and Schwab U.S. Dividend Equity ETF ($22.8M). The filing reflects a diversified, income-oriented strategy with significant exposure to municipal bonds, dividend equities, and broad market index funds.

• · The portfolio includes a token $2 position in Medical Marijuana Inc. (20,000 shares), likely a legacy or speculative holding.
• · Fixed-income and balanced ETFs dominate: iShares Core 40/60 Moderate Allocation ETF ($15.6M), First Trust Low Duration Opportunities ETF ($13.3M), iShares National Muni Bond ETF ($10.2M), and State Street SPDR Portfolio Aggregate Bond ETF ($18.9M).
• · Equity exposure includes individual stocks such as Deere & Co. ($5.8M), Tesla ($491K), Ford ($134K), and U.S. Bancorp ($1.4M).
• · The filing was signed by Jacqueline Stoffel, Operations Manager, on July 14, 2026.

15-07-2026

707 Cayman Holdings Limited filed a Form 6-K with the SEC on July 15, 2026, reporting that it effected a share consolidation on July 14, 2026. The press release attached as Exhibit 99.1 provides further details on the reverse stock split. No financial results or period-over-period comparisons were included in this filing.

• · Share consolidation (reverse stock split) effective July 14, 2026.
• · Company address: 5/F, AIA Financial Centre, 712 Prince Edward Road East, San Po Kong, Hong Kong.
• · SEC Commission File Number: 001-42688.
• · Registrant files annual reports under Form 20-F.

15-07-2026

Galapagos NV (GLPGF) filed a Form 6-K with the SEC on July 15, 2026, attaching a press release issued on July 14, 2026. The filing is a routine foreign issuer report and does not contain any financial results, operational updates, or material events beyond the press release itself.

• · The press release is dated July 14, 2026.
• · The filing incorporates the press release into multiple Registration Statements on Form S-8.
• · The registrant's name translated into English is Lakefront Biotherapeutics.
• · The principal executive office is located in Mechelen, Belgium.

15-07-2026

Altium Investment Strategies LLC filed its quarterly 13F-HR for the period ending June 30, 2026, disclosing 20 equity holdings with a total market value of approximately $69.4 million. The portfolio is heavily weighted toward fixed-income and income-oriented ETFs, with the largest positions in First Trust Enhanced Short Maturity ETF ($16.1M) and Procter & Gamble ($14.8M). The filing reflects a conservative, income-focused strategy with no period-over-period comparison data provided.

• · The portfolio includes a small allocation to cryptocurrency-related assets: Grayscale Chainlink Trust ($105,450) and Hyperliquid Strategies Inc ($128,350).
• · Fixed-income ETFs dominate the top holdings, with First Trust Enhanced Short Maturity ETF and Global X 1-3 Month T-Bill ETF together representing about 41% of total portfolio value.
• · The only individual equity positions are Alphabet Inc ($471,480), Amazon.com Inc ($439,404), and Procter & Gamble Co ($14.8M).
• · No period-over-period comparison data is available in this filing, so portfolio changes cannot be assessed.

15-07-2026

Accurate Wealth Management, LLC reported its quarterly 13F-HR holdings for the period ending June 30, 2026, disclosing 576 positions with a total market value of approximately $1,040,859,393. Concentration is notably high in technology and large-cap ETFs, with NVIDIA Corporation ($52.2M), Procter & Gamble ($27.7M), and Apple Inc. ($41.9M) among the top equity holdings. The portfolio is heavily weighted toward fixed-income and cash-equivalent ETFs—particularly the iShares 0-3 Month Treasury ETF ($6.8M) and the Global X 1-3 Month T-Bill ETF ($21.3M)—suggesting a defensive posture alongside growth exposure.

• · No prior period data is provided in this initial filing, so quarter-over-quarter changes cannot be assessed.
• · Top 5 positions by market value: NVIDIA ($52.2M), Procter & Gamble ($27.7M), Apple ($41.9M), First Trust Enhanced Short Maturity ETF ($34.4M), Microsoft ($16.8M).
• · Significant fixed-income/cash ETF holdings: iShares 0-3 Month Treasury ($6.8M), Global X 1-3 Month T-Bill ($21.3M), iShares Core US Aggregate Bond ($11.1M).
• · Notable holdings in defense/aerospace: RTX Corporation ($2.4M), General Dynamics ($2.1M), L3Harris Technologies ($0.9M), Howmet Aerospace ($2.8M).

15-07-2026

Jones Ventures INTL Acquisition1 Corp priced its initial public offering of 20,000,000 units at $10.00 per unit, raising $200,000,000. The units consist of one Class A ordinary share and one right to receive one-eighth of a Class A ordinary share upon a business combination. The Sponsor and underwriter have committed to purchase 645,000 private placement units for $6,450,000, and the Sponsor previously purchased 7,666,667 Class B ordinary shares for $25,000, creating significant dilution risk for public shareholders. The filing also highlights substantial conflicts of interest, including a potential $8,000,000 marketing fee to an affiliate of the underwriter upon completion of a business combination.

• · The underwriters have a 45-day option to purchase up to an additional 3,000,000 units to cover over-allotments.
• · Public shareholders have redemption rights upon completion of the initial business combination, but shareholders holding more than 15% of shares sold in the offering are restricted from redeeming more than 15% without prior consent if a shareholder vote is held.
• · The Class B ordinary shares convert into Class A ordinary shares on a one-for-one basis, subject to anti-dilution adjustments that could result in a greater than one-for-one conversion ratio.
• · The Sponsor's founder shares were purchased at a nominal price of approximately $0.003 per share, creating immediate and substantial dilution for public shareholders.
• · The Sponsor and its affiliates may have conflicts of interest because they could profit even if the business combination is unprofitable for public shareholders.
• · If no business combination is completed within the completion window, founder shares and private placement units may expire worthless, creating an incentive to complete a transaction even if it declines in value.
• · Jones, an affiliate of the Sponsor, will receive a marketing fee of $8,000,000 (up to $9,800,000 with full over-allotment) upon closing of the initial business combination.

15-07-2026

Avanos Medical, Inc. filed a supplemental proxy statement on July 15, 2026, in response to two shareholder lawsuits and demand letters alleging disclosure deficiencies in the definitive proxy statement related to its proposed merger with affiliates of AIP. The company denies the allegations but voluntarily supplements disclosures, including additional details on UBS's conflict of interest and fees, the absence of pre-merger discussions regarding executive employment, and expanded financial forecasts and valuation analyses. The merger consideration remains $25.00 per share, and the board continues to unanimously recommend approval at the special meeting on July 22, 2026.

• · Two lawsuits (Williams v. Avanos Medical, Inc. et al. and Stevens v. Avanos Medical, Inc. et al.) were filed on June 29-30, 2026, seeking to enjoin the merger.
• · UBS will receive an estimated fee of not more than $5 million from the company upon consummation of the merger.
• · No substantive discussions occurred between AIP and Avanos regarding executive employment termination or retention prior to the merger agreement execution.
• · JP Morgan's public trading multiples analysis implied a per-share equity value range of $12.75 to $23.50, compared to the merger consideration of $25.00.
• · The selected transactions analysis included a range of FV/LTM Adj. EBITDA multiples from 7.0x to 12.6x, with a median of 9.4x.
• · The special meeting is scheduled for July 22, 2026.